Top Section/Ad
Top Section/Ad
Most recent
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
◆ Single digit premiums offered ◆ Reverse Yankees dominating euro supply ◆ Floaters proving popular with multi-tranche issuers
Pair enjoyed strong execution and tight pricing as US high grade credit remained resilient in the face of a sell-off in equity markets
More articles/Ad
More articles/Ad
More articles
-
European IPO bankers have renewed their focus on bringing growth-orientated technology companies to market in the autumn, rather than cyclical firms, as fears over the continuing spread of Covid-19 leading to a fresh wave of lockdowns at the end of the year persist. -
Sri Lanka's dollar bonds bounced back at the end of last week, following news that the country's central bank is ready to repay debt set to mature this month.
-
The Basel Committee on Banking Supervision has completed a report looking at lessons learned from the coronavirus pandemic, but it has stopped short of recommending any changes to the regulatory capital framework.
-
Shanghai Pharmaceuticals Holding Co has managed to slice the margin and fees on a $500m comeback to the loan market.
-
LinkDoc Technology, a cancer-focused medical data company, has shelved its US IPO just hours before pricing, as Chinese technology stocks recoil from Beijing’s clampdown on overseas listings.
-
EMC, the Russian private healthcare company, has unveiled the price range for its IPO on the Moscow Exchange.
